Tilray® Exports First Shipment of health Cannabis to Spain

NANAIMO, Uk Columbia–(BUSINESS WIRE)–Tilray, Inc. (NASDAQ: TLRY), a pioneer that is global cannabis research, cultivation, production, and distribution, today announced it has agreed with Worldpharma Biotech (“Worldpharma”), through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. (“Tilray Portugal”), to export good processes that are manufacturingGMP) certified medical cannabis from Portugal to Spain. The delivery marks the very first medical cannabis import into Spain by Worldpharma while the 17(* that is*)th( country to receive Tilray medical worldwide.cannabisThe Agencia Española de Medicamentos y Productos Sanitorios (AEMPS), Spain’s drug and food management, has authorized Worldpharma to import Tilray’s GMP-certified medical

as natural product from the Portugal center to Spain. With Tilray’s pharmaceutical-grade cannabis, Worldpharma will establish medical cannabis items for medical studies in Spanish Hospitals for conditions such as for example Alzheimer’s, Parkinson’s condition, and epidermis irritation.cannabisBrendan Kennedy, Tilray’s ceo, said, “We’re incredibly honored to be 1st

business become authorized and to deliver medical cannabis into Spain. We are grateful to partner with the AEMPS and established pharmaceutical leaders such as Worldpharma Biotech on the distribution of Tilray medical

.”cannabisJuan as we continue to work with regulators around the world Jose Garcia Miquel, Founder of World Pharma Biotech, said, “We are very happy to initiate a* that is( biomass supply contract with Tilray to produce our removal and purification lab with quality GMP certified products which meet with the greatest of E.U. and Spanish Pharmacology guidelines. We plan to use the businesses utilizing the quality that is highest pharmaceutical standards to give doctors and patients total confidence. It’s been impossible to reach this level of quality from other* that is( authorized organizations in Spain.”cannabisSascha Mielcarek, Tilray’s General Manager for European countries, stated, “We are extremely happy to partner with Worldpharma. Tilray is once more developing it self as a vital player with solid expertise within the ongoing service of patient well-being. Throughout its supply chain, Tilray applies the highest medical standards that provide sustainable and access that is safe pharmaceutical-grade medical cannabis for clients in need of assistance, paving the way in which for future medical

requirements of care.”cannabisTilray has a pioneering track record as an organization focused on making GMP-certified, pharmaceutical-grade medical cannabis items open to clients in need of assistance all over the world and ended up being the first ever to effectively export medical cannabis from the united states and import medical

items in to the E.U. in 2016.cannabisTilray’s E.U. Campus in Portugal is a production that is multi-faceted that includes research and quality control labs, packaging, and distribution sites for medical cannabis. It also serves as a hub supporting Tilray’s research that is clinical item development efforts across European countries. Tilray has generated product sales and circulation plans to produce medical cannabis through major distribution that is pharmaceutical throughout Germany and the E.U., which will serve as a means to allowing patients to access Tilray’s GMP-certified finished medical


About Tilray®cannabisTilray is a pioneer that is global the study, cultivation, manufacturing, and distribution of

and cannabinoids, presently serving tens and thousands of clients and customers in 17 nations spanning five continents.

About WorldPharma Biotech

World Pharma Biotech ended up being launched in 2014 in Valencia, Spain, dedicated to vegetal components for nutraceuticals, cosmetic makeup products, and industries that are pharmaceutical. The company is located in the Scientific Park of the University of Valencia, a center of Spin-off and companies that are start-up Valencia University. The extraction and purification lab’s focus that is primary the manufacturing of Active Pharmaceutical Ingredients from Cannabis for the European Pharmaceutical and Dermo Cosmetic Industry.

Forward-Looking Statements

Share this:

Get Real-Time Updates from MJobserver.com(*)

Latest posts